Tranzactioneaza Latigo Biotherapeutics, Inc (US.LTGO) - 22.55 USD (%) Tranzactioneaza
1D
1W
1M
3M
6M
1Y
5Y
Max
Indici
Descriere companie
Latigo Biotherapeutics, Inc. is a company based in Thousand Oaks, California, developing non-opioid pain medicines intended to block pain transmission without the addiction risk associated with conventional analgesics. Its pipeline is built around NaV1.8 inhibition and comprises LTG-001, an oral candidate offering fast-acting, opioid-sparing relief in acute pain; LTG-321, aimed at chronic musculoskeletal pain with osteoarthritis as the initial indication; and LTG-418, developed for both acute and chronic pain. Incorporated in 2018, the company previously operated under the name WVB-Desmond, Inc. before adopting its current name in March 2019.